{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:41:08Z","timestamp":1787236868195,"version":"build-2736575974"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153696","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T13:30:44Z","timestamp":1461331844000},"page":"e0153696","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":111,"title":["Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4570-3266","authenticated-orcid":true,"given":"Tat Ming","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy X.","family":"Khong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick N. A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha P.","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Tambyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Lye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"DL Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhin.2009.02.021","article-title":"Extended-spectrum beta-lactamase-producing organisms","volume":"73","author":"ME Falagas","year":"2009","journal-title":"J Hosp Infect"},{"issue":"Suppl 1","key":"ref3","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1111\/j.1469-0691.2007.01867.x","article-title":"The spread of CTX-M-type extended-spectrum beta-lactamases","volume":"14","author":"GM Rossolini","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1345\/aph.1K213","article-title":"Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms","volume":"41","author":"K Yang","year":"2007","journal-title":"Ann Pharmacother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","year":"2004","journal-title":"Am J Infect Control"},{"issue":"Suppl 1","key":"ref6","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1111\/j.1469-0691.2007.01850.x","article-title":"Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe","volume":"14","author":"R Canton","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1128\/AAC.00971-12","article-title":"Distribution of extended-spectrum beta-lactamases, AmpC beta-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-pacific region: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"57","author":"WH Sheng","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jac\/dki166","article-title":"Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community","volume":"56","author":"JD Pitout","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1471-2334-14-298","article-title":"A prospective observational study of the prevalence and risk factors for colonization by antibiotic resistant bacteria in patients at admission to hospital in Singapore","volume":"14","author":"BE Young","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3201\/eid1312.070299","article-title":"Antimicrobial drug resistance in Singapore hospitals","volume":"13","author":"LY Hsu","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jinf.2007.04.007","article-title":"Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing <italic>E<\/italic>. <italic>coli<\/italic> compared to non-ESBL producing <italic>E<\/italic>. <italic>coli<\/italic>","volume":"55","author":"M Melzer","year":"2007","journal-title":"J Infect"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/420816","article-title":"Antibiotic therapy for <italic>Klebsiella pneumoniae<\/italic> bacteraemia: implications of production of extended-spectrum beta-lactamases","volume":"39","author":"DL Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4065\/mcp.2010.0674","article-title":"Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant <italic>Pseudomonas aeruginosa<\/italic>","volume":"86","author":"SS Kanj","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"Beta-Lactam\/beta-lactam inhibitor combinations for the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing <italic>Escherichia coli<\/italic>: a post hoc analysis of prospective cohorts","volume":"54","author":"J Rodriguez-Bano","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/jac\/dkt450","article-title":"Determining a clinical framework for use of cefepime and beta-lactam\/beta-lactamase inhibitors in the treatment of infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae","volume":"69","author":"HM Nguyen","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis","volume":"67","author":"KZ Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of carbapenemase-producing Enterobacteriaceae","volume":"17","author":"P Nordmann","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"KK Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/cir273","article-title":"Country-to-country transfer of patients and the risk of multi-resistant bacterial infection","volume":"53","author":"BA Rogers","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1473-3099(11)70056-1","article-title":"Metallo-beta-lactamases: a last frontier for beta-lactams?","volume":"11","author":"G Cornaglia","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/cid\/cir202","article-title":"Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention","volume":"53","author":"N Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"JS Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care\u2014associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"ND Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"MA Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1128\/AAC.48.12.4574-4581.2004","article-title":"Bloodstream infections due to extended-spectrum beta-lactamase-producing <italic>Escherichia coli<\/italic> and <italic>Klebsiella pneumoniae<\/italic>: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy","volume":"48","author":"CI Kang","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1756-0500-3-116","article-title":"Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing <italic>Escherichia coli<\/italic> and <italic>Klebsiella pneumoniae<\/italic>","volume":"3","author":"VP Chaubey","year":"2010","journal-title":"BMC Res Notes"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1017\/ice.2015.101","article-title":"Carbapenems versus piperacillin-tazobactam for bloodstream infections of nonurinary source caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"36","author":"H Ofer-Friedman","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum beta-lactamase bacteraemia","volume":"60","author":"PD Tamma","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1469-0691.2009.02893.x","article-title":"Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing <italic>Escherichia coli<\/italic> isolates","volume":"16","author":"L Lopez-Cerero","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jinf.2012.01.008","article-title":"Piperacillin-tazobactam as an initial empirical therapy of bacteraemia caused by extended-spectrum beta-lactamase-producing <italic>Escherichia coli<\/italic> and <italic>Klebsiella pneumoniae<\/italic>","volume":"64","author":"CI Kang","year":"2012","journal-title":"J Infect"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2796.1998.00379.x","article-title":"The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection","volume":"244","author":"L Leibovici","year":"1998","journal-title":"J Intern Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13063-014-0541-9","article-title":"Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible <italic>Escherichia coli<\/italic> and <italic>Klebsiella spp<\/italic>. (the MERINO trial): study protocol for a randomised controlled trial","volume":"16","author":"PN Harris","year":"2015","journal-title":"Trials"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T17:19:38Z","timestamp":1748884778000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153696"}},"subtitle":[],"editor":[{"given":"John","family":"Conly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,22]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153696","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,22]]}}}